Added to YB: 2026-01-09
Pitch date: 2026-01-05
NXS.AX [neutral]
Next Science Limited
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.
Market Cap
AUD 28.3M
Pitch Price
N/A
Price Target
0.15 (+7%)
Dividend
N/A
EV/EBITDA
-4.08
P/E
-2.99
EV/Sales
1.48
Sector
Health Care Equipment and Supplies
Category
special_situation
Liquidations Newsletter - Updates on Previously Mentioned: Next Science Limited
NXS.AX (liquidation update): Board called EGM in Jan to vote on initial return of capital $0.145/share, then wind up company. Confirmed liquidation from potential. Final distribution by liquidator from residue. Est NAV $0.155/share total distribution. 1yr timeframe.
Read full article (1 min)